Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
International Journal of Cancer|July 29, 2011
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cellsPetra Baumgaertner, Camilla Jandus, Jean-Paul Rivals, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2012
KAP1 regulates gene networks controlling T-cell development and responsivenessFrancesca R Santoni de Sio, Isabelle Barde, Sandra Offner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2012
The T-cell receptor is not hardwired to engage MHC ligandsStephen J Holland, Istvan Bartok, Meriem Attaf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cellsCatherine Barbey, Petra Baumgaertner, Estelle Devevre, et al.
Immunity|March 18, 2008
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytesNathalie Demotte, Vincent Stroobant, Pierre J Courtoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4Oliver Klein, Lisa M Ebert, Theo Nicholaou, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.
Plos One|September 13, 2012
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigenRona Y Zhao, Nicole A Mifsud, Kun Xiao, et al.
Pageof 5